Home › a Recro buys pain medicine, manufacturing plant in a potential $170M deal
 

Keywords :   


a Recro buys pain medicine, manufacturing plant in a potential $170M deal

2015-03-09 15:38:08| Biotech - Topix.net

Recro Pharma Inc. signed a definitive agreement Monday to acquire the rights to an experimental pain medicine and a contract manufacturing facility from Alkermes in a deal valued at up to $170 million. Under the terms of the agreement, Recro Pharma of Malvern, Pa., will make an upfront payment of $50 million to Alkermes .

Tags: potential deal medicine manufacturing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Forecast Discussion Number 19
08.11Hurricane Rafael Wind Speed Probabilities Number 19
08.11Hurricane Rafael Public Advisory Number 19
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11Harrods boss tells BBC he is 'dreadfully sorry' for Al Fayed abuse
08.11Hurricane Rafael Forecast Advisory Number 19
08.11Atlantic Tropical Weather Outlook
More »